Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Holding(s) in Company

26th Nov 2025 15:35

RNS Number : 1531J
JPMorgan Emerging EMEA Securities
26 November 2025
 

TR-1: Standard form for notification of major holdings 

ISIN 

GB0032164732 

Issuer Name 

JPMORGAN EMERGING EUROPE, MIDDLE EAST & AFRICA SECURITIES PLC  

UK or Non-UK Issuer 

UK 

An acquisition or disposal of voting rights 

Name 

Whitefort Capital Management, LP 

City of registered office (if applicable) 

Wilmington, Delaware 

Country of registered office (if applicable) 

United States 

Name 

City of registered office 

Country of registered office 

David Salanic 

N/A 

N/A 

Joseph Kaplan 

N/A 

N/A 

Name 

City of registered office 

Country of registered office 

Whitefort Capital Master Fund, LP 

Grand Cayman 

Cayman Islands 

12-Nov-2025 

13-Nov-2025 

 

% of voting rights attached to

% of voting rights through financial

Total of both in % (8.A + 8.B) 

Total number of voting

 

shares (total of

8.A) 

instruments (total of 8.B 1 + 8.B 2) 

 

rights held in issuer 

Resulting situation on the date on which threshold was crossed or reached 

18.800000 

0.000000 

18.800000 

7591473 

Position of previous notification (if applicable) 

14.240000 

0.000000 

14.240000 

Class/Type of shares ISIN code(if possible) 

Number of direct voting rights (DTR5.1) 

Number of indirect voting rights (DTR5.2.1) 

% of direct voting rights (DTR5.1) 

% of indirect voting rights (DTR5.2.1) 

GB0032164732

7591473 

18.800000 

Sub Total 8.A 

7591473 

18.800000% 

Type of financial instrument 

Expiration date 

Exercise/conversion period 

Number of voting rights that may be acquired if the instrument is exercised/converted 

% of voting rights 

Sub Total 8.B1 

Type of financial instrument 

Expiration date 

Exercise/conversion period 

Physical or cash settlement 

Number of voting rights 

% of voting rights 

Sub Total 8.B2 

 

 

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary) 

Ultimate controlling person 

Name of controlled undertaking 

% of voting rights if it equals or is higher than the notifiable threshold 

 % of voting rights through financial instruments if it equals or is

Total of both if it equals or is higher than the notifiable threshold 

 

 

 

higher than the notifiable threshold 

 

David Salanic 

Safida LLC (1) 

18.800000 

18.800000% 

Joseph Kaplan 

JK Advisors LLC

(1) 

18.800000 

18.800000% 

David Salanic 

WHITEFORT

CAPITAL

MANAGEMENT,

LP (2) 

18.800000 

18.800000% 

Joseph Kaplan 

WHITEFORT

CAPITAL

MANAGEMENT,

LP (2) 

18.800000 

18.800000% 

David Salanic 

WHITEFORT

CAPITAL GP,

LLC (3) 

18.800000 

18.800000% 

Joseph Kaplan 

WHITEFORT

CAPITAL GP,

LLC (3) 

18.800000 

18.800000% 

David Salanic 

WHITEFORT

CAPITAL

MASTER FUND,

LP (4) 

18.800000 

18.800000% 

Joseph Kaplan 

WHITEFORT

CAPITAL

MASTER FUND,

LP (4) 

18.800000 

18.800000% 

Name of the proxy holder 

The number and % of voting rights held 

The date until which the voting rights will be held 

Whitefort Capital Master Fund, LP's general partner is Whitefort Capital 

GP, LLC (the "GP"). The GP has delegated voting rights to Whitefort Capital Management, LP (the "Manager") pursuant to an investment management agreement. The Manager is controlled jointly by (1) Safida, LLC, which is, in turn, controlled by David Salanic, and (2) JK Advisors, LLC, which is, in turn, controlled by Joseph Kaplan. 

13-Nov-2025

New York, NY, USA 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLUNOVRVUUAUAA

Related Shares:

Jpmorgan Emea
FTSE 100 Latest
Value9,693.93
Change2.35